Siga Technologies (SIGA) Income towards Parent Company (2010 - 2025)
Siga Technologies (SIGA) reported Income towards Parent Company of -$6.4 million for Q3 2025, down 573.67% on a YoY basis from $1.3 million in Q3 2024, and down 117.95% quarter-over-quarter from $35.5 million in Q2 2025.
Siga Technologies (SIGA) Income towards Parent Company (2010 - 2025) Analysis & Trends
Siga Technologies has reported Income towards Parent Company for 16 years, with the latest figure at -$6.4 million in Q3 2025.
- For the quarter ending Q3 2025, Income towards Parent Company fell 573.67% year-over-year to -$6.4 million; the trailing twelve-month figure through Dec 2025 stood at $28.7 million (down 51.48% YoY), and the FY2024 full-year result was $59.2 million, down 13.01% from the prior year.
- Income towards Parent Company for Q3 2025 stood at -$6.4 million, down from $35.5 million in the prior quarter.
- The five-year high for Income towards Parent Company was $73.2 million in Q4 2021, with the low at -$6.4 million in Q3 2025.
- Historically, Income towards Parent Company has averaged $13.7 million across 5 years, with a median of $167606.0 in 2021.
- Annual changes were most pronounced in 2023 — Income towards Parent Company surged 9000.73% — and 2025, when it sank 573.67%.
- Siga Technologies' Income towards Parent Company stood at $73.2 million in 2021, then slumped by 101.11% to -$811794.0 in 2022, then surged by 9000.73% to $72.3 million in 2023, then sank by 36.67% to $45.8 million in 2024, then sank by 113.91% to -$6.4 million in 2025.
- The last three Income towards Parent Company figures came in at -$6.4 million (Q3 2025), $35.5 million (Q2 2025), and -$370415.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Siga Technologies | 312.94 Mn | 157.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -6.37 Mn |
| Jun 30, 2025 | 35.47 Mn |
| Mar 31, 2025 | -370,415.00 |
| Dec 31, 2024 | 45.76 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 1.80 Mn |
| Mar 31, 2024 | 10.32 Mn |
| Dec 31, 2023 | 72.26 Mn |
| Sep 30, 2023 | -393,066.00 |
| Jun 30, 2023 | -2.85 Mn |
| Mar 31, 2023 | -918,255.00 |
| Dec 31, 2022 | -811,794.00 |
| Sep 30, 2022 | 33.04 Mn |
| Jun 30, 2022 | 1.99 Mn |
| Mar 31, 2022 | -364,455.00 |
| Dec 31, 2021 | 73.21 Mn |
| Sep 30, 2021 | -3.08 Mn |
| Jun 30, 2021 | 167,606.00 |
| Mar 31, 2021 | -812,105.00 |
| Dec 31, 2020 | 20.18 Mn |